Novolog (pharm Up 1966) Ltd.TASE: NVLG

NVLG: H1 2024 revenue up 11.5% to ₪1.64B; net income stable; ₪15M dividend declared

· Issued by Novolog (pharm Up 1966) Ltd.

Revenue grew 11.5% year-over-year to ₪1.64B in H1 2024, with net income stable at ₪13.3M and Adjusted EBITDA up 3.7%. Dividend of ₪15M declared; no material impact from Israel's credit downgrade.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.